| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 16 |
| 1 | ASPIRIN 325 MG | 16 |
| 2 | ASPIRIN 81 MG | 16 |
| 3 | SACUBITRIL AND VALSARTAN | 14 |
| 4 | FUROSEMIDE | 10 |
| 5 | CARVEDILOL | 9 |
| 6 | METOPROLOL TARTRATE | 9 |
| 7 | CLOPIDOGREL | 8 |
| 8 | METOPROLOL | 8 |
| 9 | OMEPRAZOLE MAGNESIUM | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHENODIOL | 1 | 0.0028 |
| 1 | TRIMIPRAMINE | 1 | 0.0009 |
| 2 | OMEGA-3-ACID ETHYL ESTERS | 1 | 0.0005 |
| 3 | ESTRADIOL/NORETHINDRONE ACETATE | 1 | 0.0005 |
| 4 | FOSINOPIRL SODIUM | 1 | 0.0005 |
| 5 | FLUDROCORTISONE ACETATE | 1 | 0.0004 |
| 6 | REGADENOSON | 2 | 0.0004 |
| 7 | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0003 |
| 8 | PACRITINIB | 1 | 0.0003 |
| 9 | RANOLAZINE | 3 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Anti-anginal [EPC] | 3 | 0.0003 |
| 2 | Adenosine Receptor Agonist [EPC] | 2 | 0.0003 |
| 3 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 2 | 0.0002 |
| 4 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 5 | PCSK9 Inhibitor [EPC] | 4 | 0.0002 |
| 6 | Thymic Stromal Lymphopoietin Blocker [EPC] | 1 | 0.0001 |
| 7 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 8 | Intestinal Lipase Inhibitor [EPC] | 2 | 0.0001 |
| 9 | Nitrate Vasodilator [EPC] | 7 | 0.0001 |